Case Report
BibTex RIS Cite

Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity

Year 2014, Volume: 27 Issue: 2 , 129 - 131 , 20.05.2014

Ayşegül Üçüncü Kefeli Beste Melek Atasoy , Zerrin Özgen Murat Sarı Fuat Dede Faysal Dane

https://izlik.org/JA96HZ42ZS

Abstract

Mastoid region recurrence is a rare entity for nasopharyngeal
cancer. This paper presents a patient with an isolated mastoid
recurrence following definitive treatment and discusses the
therapeutic approach which may help in the treatment of such cases.

Keywords

Chemotherapy Mastoid region recurrence Nasopharyngeal carcinoma Radiotherapy

References

  • 1. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-44. doi:10.1016/j. semradonc.2012.03.008
  • 2. Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology? Kulak Burun Bogaz Ihtis Derg 2010;20:89-96.
  • 3. Atasoy BM, Dane F, Yumuk PF, et al. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON 2008;13:43-50.
  • 4. Zhang X, Luo J, Gao L, Xu G. Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies. Head Neck 2011;33:1535-8. doi: 10.1002/hed.21391
  • 5. Yang MS, Chen CC, Cheng YY, et al. Nasopharyngeal carcinoma spreading along the eustachian tube: the imaging appearance. J Chin Med Assoc 2004;67:200-3.
  • 6. Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol 2007;17:2622-30. doi:10.1007/s00330-007-0616-z
  • 7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook from the AJCC cancer staging manual. 6th ed. New York, Springer: 2002.

Nazofarenks kanserinin mastoid bölge rekürrensi: Nadir bir klinik tablonun tedavisi

Year 2014, Volume: 27 Issue: 2 , 129 - 131 , 20.05.2014

Ayşegül Üçüncü Kefeli Beste Melek Atasoy , Zerrin Özgen Murat Sarı Fuat Dede Faysal Dane

https://izlik.org/JA96HZ42ZS

Abstract

Nazofarenks kanserinde mastoid rekürrens takipte nadir izlenen bir
durumdur. Bu makale definitif tedavi sonrası izlenen izole mastoid
nüksünü sunmakta ve tedavisini tartışmaktadır. 

Keywords

Kemoterapi Mastoid bölge nüksü Nazofarenks kanseri Radyoterapi

References

  • 1. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-44. doi:10.1016/j. semradonc.2012.03.008
  • 2. Atasoy BM, Ozyar E, Akman F, Esassolak M, Abacioğlu U. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology? Kulak Burun Bogaz Ihtis Derg 2010;20:89-96.
  • 3. Atasoy BM, Dane F, Yumuk PF, et al. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J BUON 2008;13:43-50.
  • 4. Zhang X, Luo J, Gao L, Xu G. Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies. Head Neck 2011;33:1535-8. doi: 10.1002/hed.21391
  • 5. Yang MS, Chen CC, Cheng YY, et al. Nasopharyngeal carcinoma spreading along the eustachian tube: the imaging appearance. J Chin Med Assoc 2004;67:200-3.
  • 6. Dubrulle F, Souillard R, Hermans R. Extension patterns of nasopharyngeal carcinoma. Eur Radiol 2007;17:2622-30. doi:10.1007/s00330-007-0616-z
  • 7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook from the AJCC cancer staging manual. 6th ed. New York, Springer: 2002.
There are 7 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Case Report
Authors

Ayşegül Üçüncü Kefeli This is me

Beste Melek Atasoy

Zerrin Özgen This is me

Murat Sarı This is me

Fuat Dede This is me

Faysal Dane This is me

Publication Date May 20, 2014
IZ https://izlik.org/JA96HZ42ZS
Published in Issue Year 2014 Volume: 27 Issue: 2

Cite

APA Üçüncü Kefeli, A., Atasoy, B. M., Özgen, Z., Sarı, M., Dede, F., & Dane, F. (2014). Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal, 27(2), 129-131. https://izlik.org/JA96HZ42ZS
AMA 1.Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. 2014;27(2):129-131. https://izlik.org/JA96HZ42ZS
Chicago Üçüncü Kefeli, Ayşegül, Beste Melek Atasoy, Zerrin Özgen, Murat Sarı, Fuat Dede, and Faysal Dane. 2014. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal 27 (2): 129-31. https://izlik.org/JA96HZ42ZS.
EndNote Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F (May 1, 2014) Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Medical Journal 27 2 129–131.
IEEE [1]A. Üçüncü Kefeli, B. M. Atasoy, Z. Özgen, M. Sarı, F. Dede, and F. Dane, “Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity”, Marmara Med J, vol. 27, no. 2, pp. 129–131, May 2014, [Online]. Available: https://izlik.org/JA96HZ42ZS
ISNAD Üçüncü Kefeli, Ayşegül - Atasoy, Beste Melek - Özgen, Zerrin - Sarı, Murat - Dede, Fuat - Dane, Faysal. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal 27/2 (May 1, 2014): 129-131. https://izlik.org/JA96HZ42ZS.
JAMA 1.Üçüncü Kefeli A, Atasoy BM, Özgen Z, Sarı M, Dede F, Dane F. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J. 2014;27:129–131.
MLA Üçüncü Kefeli, Ayşegül, et al. “Recurrence of Nasopharyngeal Carcinoma in the Mastoid Region: Therapeutic Approach of a Rare Clinical Entity”. Marmara Medical Journal, vol. 27, no. 2, May 2014, pp. 129-31, https://izlik.org/JA96HZ42ZS.
Vancouver 1.Ayşegül Üçüncü Kefeli, Beste Melek Atasoy, Zerrin Özgen, Murat Sarı, Fuat Dede, Faysal Dane. Recurrence of nasopharyngeal carcinoma in the mastoid region: Therapeutic approach of a rare clinical entity. Marmara Med J [Internet]. 2014 May 1;27(2):129-31. Available from: https://izlik.org/JA96HZ42ZS